Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: A randomized controlled trial

Acta Neurologica Scandinavica

Volumn 129, Issue 3, 2014, Pages 143-153

  French, J A ^a   Baroldi, P ^b,c   Brittain, S T ^b   Johnson, J K ^b   Abou Khalil, Bassel ^d   Brower, Richard ^d   Burdette, David ^d   Cantero, Julio ^d   Carran, Melissa ^d   Chumley, Warren ^d   Chung, Steve ^d   DeCerce, John ^d   Dhaduk, Vithalbhai ^d   Evans, Stephen ^d   Feldman, Jessica ^d   Ferencz, Gerald ^d   Fessler, James ^d   Fisher, Mark ^d   Flitman, Stephen ^d   Gerner, Robert ^d   Gibson, Gordon ^d   Harris, Michael ^d   Hull, Richard ^d   Ibrahim, Waseem ^d   Jacobson, Alan F ^d   Kirmani, Batool ^d   Klein, Pavel ^d   Mahdad, Michael M ^d   Marsella, Gregory ^d   Mate, Laszlo ^d   McPherson, Selwyn Lloyd ^d   Morris, George ^d   Olenjiczak, Piotr ^d   Pang, Trudy ^d   Pardo, Ricardo ^d   Pollard, John ^d   Savit, Jan ^d   Shihabuddin, Bashir ^d   Strom, Laura ^d   Swanson, Thomas ^d   Teeple, David ^d   Todorov, Alexandre ^d   Uddin, Sala ^d   Vazquez, Blanca ^d   Verson, Reinaldo ^d   Vidic, Thomas ^d   Wallis, Roi Ann ^d   Waterhouse, Elizabeth ^d   Yapundich, Robert ^d   Ahmed, S Nizam ^d   Clement, Jean Francois ^d   Pillay, Neelan ^d   Veilleux, Martin ^d   Alemán Pedroza, Jose ^d   Castro Farfan, Freddy ^d   Díaz Juarez, Eduardo ^d   Escamilla Garza, Juan ^d   Pérez Garcia, Juan ^d   Rángel Guerra, Ricardo ^d   Renteria Bilbao, Mariela ^d   Reyes Morales, Sarug ^d   Rodriguez Leyva, Ildefonso ^d   Ruiz Sandoval, Jose ^d   Sanchez Arrioja, Gustavo ^d   Silva Sanchez, Sandra ^d   Vega Boada, Felipe ^d   Deleva, Nadezhda ^d   Kalpachki, Rosen ^d   Kastrev, Sasho ^d   Maslarov, Dimitar ^d   Petrova, Neli ^d   Shotekov, Penko ^d   Staikov, Ivan ^d   Stamenova, Paraskeva ^d   Tsvetanov, Plamen ^d   Zahariev, Zahari ^d   Basic, Silvio ^d   Glavic, Josip ^d   Hecimovic, Hrvoje ^d   Jurjevic, Ante ^d   Mrden, Anamarija ^d   Poljakovic, Zdravka ^d   Susak, Renata ^d   Brola, Waldemar ^d   Czapinski, Piotr ^d   Czlonkowska, Anna ^d   Drozdowski, Wieslaw ^d   Fiszer, Urszula ^d   Kapelusiak Pielok, Magdelena ^d   Mazurkiewicz Beldinska, Maria ^d   Moskal, Wojciech ^d   Motta, Ewa ^d   Nastaj, Marcin ^d   Opala, Grzegorz ^d   Pierzchala, Krystyna ^d   Radman, Artur ^d   Rosochowicz, Tomascz ^d   Rozniecki, Jacek ^d   Tutaj, Andrzej ^d   Wlodek, Agata ^d   Zubiel, Maria ^d   Bulboaca, Corneliu Angelo ^d   Chiru, Mirela ^d   Manescu, Silviu ^d   Marginean, Ioan ^d   Zaharia, Cornelia ^d   Agafina, Alina ^d   Avakyan, Gagik ^d   Belova, Anna ^d   Beyn, Boris ^d   Bogdanov, Enver ^d   Gofman, Alexander ^d   Gustov, Alexander ^d   Koroleva, Nadezhda ^d   Laskov, Vitaliy ^d   Maslova, Natalia ^d   Mishin, Gennadiy ^d   Pankratov, Eugeny ^d   Pizova, Natalia ^d   Poverenova, Irina ^d   Skoromets, Alexander ^d   Vostrikova, Elena ^d   Yakupov, Eduard ^d   Zaslavskiy, Leonid ^d   more..

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Supernus Pharmaceuticals Inc   (United States)

^c Vanda Pharmaceuticals   (United States)

^d NONE

Author keywords

Adjunctive therapy; Extended release oxcarbazepine; Partial onset seizures; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; OXCARBAZEPINE; SODIUM;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; ARTICLE; ASTHENIA; BALANCE DISORDER; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPONATREMIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; REFRACTORY PARTIAL ONSET SEIZURE; SEIZURE; SENSITIVITY ANALYSIS; SODIUM BLOOD LEVEL; SOMNOLENCE;

ADJUNCTIVE THERAPY; EXTENDED-RELEASE OXCARBAZEPINE; PARTIAL-ONSET SEIZURES; REFRACTORY EPILEPSY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84893695464     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12207     Document Type: Article

References (25)

1. Koch MW, Polman SK. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. Cochrane Database Syst Rev 2009; CD006453.
2. Flesch G, Czendlik C, Renard D et al. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. Drug Metab Dispos 2011;39:1103-10.
3. Flesch G, Czendlik C, Renard D et al. Trileptal prescribing information. Novartis Pharmaceuticals. Revised March, 2011.
4. Barcs G, Walker E, Elger C et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-607.
5. Edelbroek PM, Augustijn PB, de Haan GJ et al. Change in oxcarbazepine (Trileptal) formulation is associated with more side effects and higher blood concentrations. J Neurol Neurosurg Psychiatry 2001;71:708-9.
6. Striano S, Striano P, di Nocera P et al. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. Epilepsy Res 2006;69:170-6.
7. Striano S, Striano P, Di Nocera P et al. Oxtellar prescribing information. Supernus Pharmaceuticals, Inc. Revised October 2012.
8. Bancaud J, Henriksen O, Rubio-Donnadieu F et al. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489-501.
9. Noether GE. Sample size determination for some common nonparametric tests. J Am Stat Ass 1987;82:645-7.
10. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
11. Gazzola DM, Balcer LJ, French JA. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007;48:1303-7.
12. Rheims S, Perucca E, Cucherat M et al. Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis. Epilepsia 2011;52:219-33.
13. French JA, Krauss GL, Biton V et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012;79:589-96.
14. Schmidt D, Beyenburg S, D'souza J et al. Clinical features associated with placebo response in refractory focal epilepsy. Epilepsy Behav 2013;27:393-8.
15. Cramer J, Vachon L, Desforges C et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995;36:1111-7.
16. Cramer JA, Mattson RH, Prevey ML et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-7.
17. Coleman CI, Limone B, Sobieraj DM et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm 2012;18:527-39.
18. Srivastava K, Arora A, Kataria A et al. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence 2013;7:419-34.
19. Faught E, Duh MS, Weiner JR et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study. Neurology 2008;71:1572-8.
20. Ettinger AB, Manjunath R, Candrilli SD, et al. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009;14:324-9.
21. Manjunath R, Davis KL, Candrilli SD et al. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009;14:372-8.
22. Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008;49:446-54.
23. Perucca E. Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilepsy Curr 2009;9:153-7.
24. Brodie M, Overstall P, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-7.
25. Saetre E, Perucca E, Isojarvi J et al. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-302.